Raymond Pratt - Dec 14, 2023 Form 4 Insider Report for Savara Inc (SVRA)

Role: Chief Medical Officer
Signature: /s/ David Lowrance as attorney-in-fact for Raymond Pratt
Stock symbol: SVRA
Transactions as of: Dec 14, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/18/2023, 04:05 PM
Previous filing: Jun 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SVRA	Common Stock	Award	$0	+150K	+93.75%	$0.00	310K	Dec 14, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SVRA	Stock Option (Right to Buy)	Award	$0	+40K		$0.00	40K	Dec 14, 2023	Common Stock	40K	$4.45	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") that vest in full on December 14, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer.